"Move up value chain" Ireland's drug firms told

11 December 2006

Ireland's Minister for Enterprise, Trade and Employment, Michael Martin has told assembled drug industry representatives at the Irish Pharmaceutical Healthcare Association's annual meeting that the sector would "have to move up the value chain" if the country is to attract R&D investment. Mr Martin also told his audience that the Irish government, for its part, is refining the R&D tax credit.

IPHA president John McLaughlin noted that 14 of the world's top 15 research-based drugmakers have established manufacturing facilities in Ireland in the past 20 years. He added that Ireland is the largest net exporter of drugs in the world.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight